quantitative
Analysis v1
Strong Support
In patients with unexplained polyps and specific DNA damage patterns, detecting a bacterial gene in stool along with a unique tumor mutation pattern identifies colibactin exposure in 87% of cases, compared to 25% when only one method is used.
47
0
Evidence from Studies
Supporting (1)
47
Community contributions welcome
47
Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients
Cross-Sectional Study
Human
2024 Jan 18Scientists found that when they checked both poop for harmful bacteria genes and tumors for specific DNA damage patterns, they could spot colibactin’s fingerprint much better than using just one method. This helps explain why some people get lots of polyps.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.